BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6331026)

  • 1. [Cytomegalovirus infections in dialysis patients].
    Sperschneider H; Färber I; Stein G; Schneider S
    Z Urol Nephrol; 1984 Apr; 77(4):231-5. PubMed ID: 6331026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CMV infection in patients with chronic renal failure and in those following transplantation.
    Korcáková L; Kaslík J; Svobodová J; Kaslíková J; Bláha J; Sedlácková E; Franková V; Hásková V; Skibová J
    Czech Med; 1988; 11(3):131-6. PubMed ID: 2852093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus infection in dialysis patients.
    Hardiman AE; Butter KC; Roe CJ; Cunningham J; Baker LR; Kangro HO; Heath RB
    Clin Nephrol; 1985 Jan; 23(1):12-7. PubMed ID: 2983914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complications of infections attributed to cytomegalovirus in a group of 52 kidney transplant patients].
    Galezowski N; Godeaut E; Berche P; Bonissol C; Debure A; Kreis H
    Ann Med Interne (Paris); 1987; 138(5):369-71. PubMed ID: 2823666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytomegalovirus diagnosis in blood donors and risk patients].
    Sibrowski W; Kühnl P; Kalmar G; Albert S; Böhm BO; Doerr HW
    Beitr Infusionsther; 1990; 26():37-9. PubMed ID: 1703874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incidence and prognostic value of cytomegalovirus-specific antibodies of the IgM class in kidney transplant recipients].
    Eichler C; Kaden J; May G
    Z Urol Nephrol; 1990 Aug; 83(8):425-9. PubMed ID: 2173294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytomegalovirus IgM amd IgG antibodies in the sera of patients with acute and chronic upper respiratory infections].
    Cengiz AT; Ataoğlu H; Kiyan M; Kiliç H
    Mikrobiyol Bul; 1990 Oct; 24(4):307-13. PubMed ID: 1962842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections.
    Baldwin WM; van Es A; Valentijn RM; van Gemert GW; Daha MR; Vanes LA
    Clin Exp Immunol; 1982 Dec; 50(3):515-24. PubMed ID: 6299633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late onset of fatal cytomegalovirus infection after renal transplantation. Primary or reactivation infection?
    Linnemann CC; Dunn CR; First MR; Alvira M; Schiff GM
    Arch Intern Med; 1978 Aug; 138(8):1247-50. PubMed ID: 209756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between the symptomatic cytomegalovirus infection and the fluctuation of anti-CMV antibodies in patient after renal transplantation].
    Miyamoto N; Takamura Y
    Rinsho Byori; 1992 Feb; 40(2):189-93. PubMed ID: 1316499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects.
    Just-Nübling G; Korn S; Ludwig B; Stephan C; Doerr HW; Preiser W
    Infection; 2003 Oct; 31(5):318-23. PubMed ID: 14556056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
    Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel AA; Yefenof E
    Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytomegalovirus antibodies: review of results of repeated examinations in 208 hemodialyzed patients].
    Korcáková L
    Vnitr Lek; 1995 Jul; 41(7):454-7. PubMed ID: 7571479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smooth-muscle antibodies and other tissue antibodies in cytomegalovirus infection.
    Andersen P; Andersen HK
    Clin Exp Immunol; 1975 Oct; 22(1):22-9. PubMed ID: 174854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of cytomegalovirus disease after heart transplantation: persistence of anti-cytomegalovirus IgM antibodies.
    Iberer F; Halwachs-Baumann G; Rödl S; Pleisnitzer A; Wasler A; Auer T; Petutschnigg B; Müller H; Tscheliessnigg K; Wilders-Truschnig M
    J Heart Lung Transplant; 1994; 13(3):405-11. PubMed ID: 8061015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibodies to cytomegaloviruses in blood donors].
    Courault K; Lissé I; Richter H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):183-6. PubMed ID: 2475395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of cytomegalovirus infection in recipients of renal transplantation].
    Fan J; Qian J; He Q; Ma WH; Chen JH; Zhou L; Cai T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):262-4. PubMed ID: 11986702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered humoral immunity against cytomegalovirus and Epstein-Barr virus without detectable virus antigens and virus-DNA in the glomeruli of patients with IGA nephropathy in remission phase.
    Nagy J; Haikin H; Sarov B; Háber A; Kun L; Sarov I
    Acta Microbiol Immunol Hung; 1995; 42(2):179-87. PubMed ID: 7551711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMV-IGG avidity and CMV-IGM concentration in both immunocompromised and immunocompetent patients.
    Dussaix E; Chantot S; Harzic M; Grangeot-Keros L
    Pathol Biol (Paris); 1996 May; 44(5):405-10. PubMed ID: 8758485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus infection and chronic hemodialysis.
    Sexton DJ; Smith EW; Gutman RA; Helms MJ; Lang DJ
    Clin Nephrol; 1979 Jan; 11(1):3-6. PubMed ID: 218759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.